Business
PURE Bioscience to Present at the 11th Annual LD Micro Conference
PURE Bioscience to Present at the 11th Annual LD Micro Conference.
About this update from Pure Bioscience
[{"type":"text","content":"\n \n PURE Bioscience, Inc. (OTCQB: \n PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) \n antimicrobial, today announced that Hank \n R. Lambert, CEO, will present at the 11th Annual LD Micro \n Conference on Wednesday, December 5th at 11:00 am PT, at the \n Luxe Hotel Sunset Boulevard in Los Angeles.\n \n \n Lambert will discuss the Company’s dual path strategy to establish \n PURE’s non-toxic SDC antimicrobial technology as a novel and proprietary \n food safety solution (effective against pathogens including Salmonella, \n E. coli, Listeria and Norovirus):\n \n \n \n EPA registered PURE® \n Hard Surface disinfectant\n \n \n FDA approved PURE \n Control® direct food contact processing aid\n \n \n \n The presentation will be webcast live and slides may be accessed on the \n Company's website, http://www.purebio.com/investors/events-presentations/. \n The presentation will be archived for 90 days.\n \n \n About LD Micro\n \n \n LD Micro was founded in 2006 with the sole purpose of being an \n independent resource in the microcap space. What started out as a \n newsletter highlighting unique companies has transformed into several \n influential events annually (Invitational, Summit, and Main Event). In \n 2015, LDM launched the first pure microcap index (the LDMi) to \n exclusively provide intraday information on the entire sector. LD will \n continue to provide valuable tools for the benefit of everyone in the \n small and micro-cap universe. For those interested in attending, please \n contact David Scher at [email protected] \n or visit www.ldmicro.com \n for more information.\n \n \n About PURE Bioscience, Inc.\n \n \n PURE Bioscience, Inc. is focused on developing and commercializing our \n proprietary antimicrobial products primarily in the food safety arena -- \n providing solutions to the health and environmental challenges of \n pathogen and hygienic control. Our technology platform is based on \n patented stabilized ionic silver, and our initial products contain \n silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic \n antimicrobial agent, which offers 24-hour residual protection and \n formulates well with other compounds. As a platform technology, SDC is \n distinguished from existing products in the marketplace because of its \n superior efficacy, redu...